Ledger.Open graph →
SEC Form D · filed October 9, 2018

Alitair Pharmaceuticals, Inc

Offering
$32.0M
Sold
$115K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISTOWN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James E. Hoyes · Morristown, NJExec · DirectorRobert E. Casale · Morristown, NJDirectorWilliam W. Howard · Morristown, NJExec · DirectorFrank E. Guarino · Morristown, NJExecTodd Baldree · Greer, SCExec · DirectorShankar Narayana M. Narayanan · Port Luis, O4Exec · DirectorJoseph Bress · New York, NYDirectorKevin Green · BLOOMINGTON, MNExecRoss Israel · SAN FRANCISCO, CAExec · DirectorRichard Kauffman · SAN FRANCISCO, CAExecJack Stark · SAN FRANCISCO, CADirectorMatan Friedman · SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗